• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of mRNA level of the treatment resistance related proteins in unfixed lung cancer biopsy specimens obtained by core-biopsy.

Research Project

Project/Area Number 25460691
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Laboratory medicine
Research InstitutionNagasaki University

Principal Investigator

NAKAMURA Yoichi  長崎大学, 医歯薬学総合研究科(医学系), 講師 (20432974)

Co-Investigator(Kenkyū-buntansha) NAGASHIMA Seiji  長崎大学, 病院(医学系), 助教 (00646672)
FUKUDA Minoru  長崎大学, 病院(医学系), 准教授 (50388930)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Keywords非小細胞肺癌 / 個別化治療 / 個別化医療 / 肺癌化学療法
Outline of Final Research Achievements

Total mRNAs were extracted from unfixed lung cancer biopsy specimens, and each RNA level was analyzed. They are compared as ΔCT. ABC transporters; Overexpression was shown in MDR1, MRP1, BCRP. Cytoskeleton proteins; Overexpression was shown in TUBB3, and mild down regulation was shown in Gelsolin. Vascular endothelial growth factors: mild overexpression was shown in VEGF-A and VEGF-B, and overexpression was shown in VEGF-C. Cancer stem cell related antigens: Overexpression was shown in CD20, POU5F1, PROM1, Nanog, KLF4, Notch1, but CD24 and CD44 were no change.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report
  • Research Products

    (8 results)

All 2015 2014 2013

All Journal Article (4 results) (of which Peer Reviewed: 4 results,  Open Access: 4 results) Presentation (4 results) (of which Int'l Joint Research: 2 results)

  • [Journal Article] Chemotherapy2015

    • Author(s)
      Kasai T, Nakamura Y, Fukuda M, Kitazaki T, Nagashima S, Takatani H, Nakano H, Nakatomi K, Ikeda T, Yamaguchi H, Tsukamoto K, Oka M, Kohno S.
    • Journal Title

      Phase II study of S-1 for previously untreated elderly patients with advanced non-small cell lung cancer.

      Volume: 61 Issue: 2 Pages: 93-98

    • DOI

      10.1159/000441486

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapy.2015

    • Author(s)
      Mizoguchi K, Nakamura Y, Abe K, Takemoto S, Motoshima K, Ogawara D, Nakatomi K, Fukuda M, Fukuoka J, Kohno, S.
    • Journal Title

      Cancer Treat Commun

      Volume: 4 Pages: 117-120

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.2014

    • Author(s)
      Nakamura Y et al.
    • Journal Title

      Jpn J Clin Oncol

      Volume: 44 Issue: 6 Pages: 593-596

    • DOI

      10.1093/jjco/hyu028

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer2014

    • Author(s)
      Ikeda T, Fukuda M, Nakamura Y, et al.
    • Journal Title

      Cancer Chemother Pharmacol

      Volume: 74 Issue: 3 Pages: 497-502

    • DOI

      10.1007/s00280-014-2527-4

    • NAID

      120006986379

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Phase II Trial of Paclitaxel, Irinotecan, and Bevacizumab for Patients with Untreated NSCLC Overexpressed ERCC1 mRNA2015

    • Author(s)
      Nakamura Y, Yamaguchi H, Nakatomi K, et al.
    • Organizer
      World Conference on Lung Cancer 2015
    • Place of Presentation
      Denver, USA
    • Year and Date
      2015-09-06
    • Related Report
      2015 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Detection of EML4-ALK Fusion Gene by Using Nested Long-Ranged Polymerase Chain Reaction.2015

    • Author(s)
      Takemoto S, Nakamura Y, Yamaguchi H, Nakatomi K, et al.
    • Organizer
      World Conference on Lung Cancer 2015
    • Place of Presentation
      Denver, USA
    • Year and Date
      2015-09-06
    • Related Report
      2015 Annual Research Report
    • Int'l Joint Research
  • [Presentation] ゲフィチニブの薬物動態と抗腫瘍活性および有害事象との相関についての解析2014

    • Author(s)
      中村洋一
    • Organizer
      第73階日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Year and Date
      2014-10-25
    • Related Report
      2014 Research-status Report
  • [Presentation] Phase I/ II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced Non Small-cell Lung Cancer2013

    • Author(s)
      中村洋一
    • Organizer
      18th Congress of the Asian Pacific Society of Respirology
    • Place of Presentation
      Pacifico Yokohama, Yokohama, Japan
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi